Cargando…
Developing a Novel Indolocarbazole as Histone Deacetylases Inhibitor against Leukemia Cell Lines
A novel indolocarbazole (named as ZW2-1) possessing HDAC inhibition activity was synthesized and evaluated against human leukemia cell lines HL-60 and NB4. ZW2-1 performed anti-population growth effect which was in a concentration-dependent manner (2–12 μM) by inducing both apoptosis and autophagy i...
Autores principales: | Wang, Wenjing, Lv, Maomin, Zhao, Xiong, Zhang, Jingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663760/ https://www.ncbi.nlm.nih.gov/pubmed/26649226 http://dx.doi.org/10.1155/2015/675053 |
Ejemplares similares
-
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020) -
The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines
por: Bollmann, Lukas M., et al.
Publicado: (2022) -
The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020) -
Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015) -
Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
por: Sun, Yuan, et al.
Publicado: (2011)